These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 16437702

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease.
    Li A, Davila S, Furu L, Qian Q, Tian X, Kamath PS, King BF, Torres VE, Somlo S.
    Am J Hum Genet; 2003 Mar; 72(3):691-703. PubMed ID: 12529853
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Abnormal hepatocystin caused by truncating PRKCSH mutations leads to autosomal dominant polycystic liver disease.
    Drenth JP, Tahvanainen E, te Morsche RH, Tahvanainen P, Kääriäinen H, Höckerstedt K, van de Kamp JM, Breuning MH, Jansen JB.
    Hepatology; 2004 Apr; 39(4):924-31. PubMed ID: 15057895
    [Abstract] [Full Text] [Related]

  • 5. Severity in polycystic liver disease is associated with aetiology and female gender: Results of the International PLD Registry.
    van Aerts RMM, Kievit W, de Jong ME, Ahn C, Bañales JM, Reiterová J, Nevens F, Drenth JPH.
    Liver Int; 2019 Mar; 39(3):575-582. PubMed ID: 30225933
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.
    Cornec-Le Gall E, Torres VE, Harris PC.
    J Am Soc Nephrol; 2018 Jan; 29(1):13-23. PubMed ID: 29038287
    [Abstract] [Full Text] [Related]

  • 10. Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease.
    Boerrigter MM, Duijzer R, Te Morsche RHM, Drenth JPH.
    Genes (Basel); 2023 Sep 02; 14(9):. PubMed ID: 37761895
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease.
    Waanders E, te Morsche RH, de Man RA, Jansen JB, Drenth JP.
    Hum Mutat; 2006 Aug 02; 27(8):830. PubMed ID: 16835903
    [Abstract] [Full Text] [Related]

  • 13. Molecular characterization of hepatocystin, the protein that is defective in autosomal dominant polycystic liver disease.
    Drenth JP, Martina JA, Te Morsche RH, Jansen JB, Bonifacino JS.
    Gastroenterology; 2004 Jun 02; 126(7):1819-27. PubMed ID: 15188177
    [Abstract] [Full Text] [Related]

  • 14. Clinical manifestation, epidemiology, genetic basis, potential molecular targets, and current treatment of polycystic liver disease.
    Mahboobipour AA, Ala M, Safdari Lord J, Yaghoobi A.
    Orphanet J Rare Dis; 2024 Apr 26; 19(1):175. PubMed ID: 38671465
    [Abstract] [Full Text] [Related]

  • 15. Bacterial Cholangitis in Autosomal Dominant Polycystic Kidney and Liver Disease.
    Martin WP, Vaughan LE, Yoshida K, Takahashi N, Edwards ME, Metzger A, Senum SR, Masyuk TV, LaRusso NF, Griffin MD, El-Zoghby Z, Harris PC, Kremers WK, Nagorney DM, Kamath PS, Torres VE, Hogan MC.
    Mayo Clin Proc Innov Qual Outcomes; 2019 Jun 26; 3(2):149-159. PubMed ID: 31193902
    [Abstract] [Full Text] [Related]

  • 16. Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes.
    Wills ES, Cnossen WR, Veltman JA, Woestenenk R, Steehouwer M, Salomon J, Te Morsche RH, Huch M, Hehir-Kwa JY, Banning MJ, Pfundt R, Roepman R, Hoischen A, Drenth JP.
    Eur J Hum Genet; 2016 Dec 26; 24(12):1707-1714. PubMed ID: 27552964
    [Abstract] [Full Text] [Related]

  • 17. Multiple cysts in the liver autosomal dominant polycystic liver disease.
    Karimbeg AA, Loffeld RJ.
    Neth J Med; 2006 Jun 26; 64(6):199-201. PubMed ID: 16788219
    [Abstract] [Full Text] [Related]

  • 18. Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling.
    Wills ES, Te Morsche RHM, van Reeuwijk J, Horn N, Geomini I, van de Laarschot LFM, Mans DA, Ueffing M, Boldt K, Drenth JPH, Roepman R.
    Hum Mol Genet; 2017 Nov 01; 26(21):4190-4202. PubMed ID: 28973524
    [Abstract] [Full Text] [Related]

  • 19. Clinical profile of autosomal dominant polycystic liver disease.
    Qian Q, Li A, King BF, Kamath PS, Lager DJ, Huston J, Shub C, Davila S, Somlo S, Torres VE.
    Hepatology; 2003 Jan 01; 37(1):164-71. PubMed ID: 12500201
    [Abstract] [Full Text] [Related]

  • 20. Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease.
    Chebib FT, Jung Y, Heyer CM, Irazabal MV, Hogan MC, Harris PC, Torres VE, El-Zoghby ZM.
    Nephrol Dial Transplant; 2016 Jun 01; 31(6):952-60. PubMed ID: 26932689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.